A new Canadian guideline lays out the optimal strategies for providing injectable opioid agonist treatment with prescription heroin and hydromorphone for people with severe opioid use disorder.
In response to recent outbreaks of HIV and syphilis, a new harm reduction program in North Battleford, Saskatchewan aims to reduce the spread of disease through IV drug use.
